2m 2m 2m 2m 2m 2m 2m
ADC Therapeutic N (ADCT)
NYSE
$1.66-$1.51 (-47.63%)
Price as of Jun 03, 2026 6:36 PM EDT- $441.1MMarket Cap
- -11.70%1-Year Change
- BiotechnologyIndustry
ADC Therapeutic N (ADCT)
$1.66-$1.51 (-47.63%)
ADCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.17 | ||
Change | -$0.23 (-6.76%) | ||
Open | $3.36 | ||
High | $3.37 | ||
Low | $3.16 | ||
Previous Close | $3.40 | ||
Volume | 796,769 | ||
30-Day Average Volume | 1,118,245 | ||
1-Week Change | -9.69% | ||
1-Month Change | -17.23% | ||
1-Year Change | -11.70% | ||
3-Year Change | 27.31% | ||
5-Year Change | -85.94% | ||
Fundamentals | |||
Shares Outstanding | 129.7M | ||
Total Assets | $291.5M | ||
Market Cap | $441.1M | ||
Enterprise Value | $325.7M | ||
Period: QTR TTM FY | |||
Revenue | $20.9M | ||
Net Income | -$33.0M | ||
Free Cash Flow | -$29.7M | ||
EBIT | -$29.3M | ||
EBITDA | -$29.3M | ||
Net Working Capital | $209.1M | ||
EPS | -$0.21 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 16 | ||
P/B | -2 | ||
P/E | -16 | ||
PEG | 0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/10/2005 | ||
Earnings & Revenue